Compare NYT & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NYT | HSIC |
|---|---|---|
| Founded | 1851 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.8B |
| IPO Year | N/A | 1995 |
| Metric | NYT | HSIC |
|---|---|---|
| Price | $70.77 | $77.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | $63.83 | ★ $76.50 |
| AVG Volume (30 Days) | ★ 1.9M | 1.3M |
| Earning Date | 02-04-2026 | 11-04-2025 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | 21.46 | ★ 30.70 |
| EPS | 2.05 | ★ 3.17 |
| Revenue | $2,722,033,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $11.06 | $5.35 |
| Revenue Next Year | $6.86 | $3.34 |
| P/E Ratio | $34.51 | ★ $24.41 |
| Revenue Growth | ★ 8.49 | 3.51 |
| 52 Week Low | $44.83 | $60.56 |
| 52 Week High | $71.07 | $82.49 |
| Indicator | NYT | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 78.29 | 66.36 |
| Support Level | $66.87 | $76.27 |
| Resistance Level | $68.54 | $77.74 |
| Average True Range (ATR) | 1.26 | 1.37 |
| MACD | 0.32 | 0.05 |
| Stochastic Oscillator | 98.69 | 92.12 |
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.